{"company":{"id":1777419,"name":"Neurocrine Biosciences","domain":"neurocrine.com","url":"https://alion.io/company/neurocrine"},"answer":"As of Nov 14, 2026, Alion lists 10 companies most like Neurocrine Biosciences: Takeda Pharmaceutical, Acadia Pharmaceuticals, Biogen, Ipsen, Ovid Therapeutics, AbbVie, Alnylam, Alkermes, Vertex Pharmaceuticals and BridgeBio Pharma.","highlights":["Neurocrine Biosciences itself has 77 open roles on Alion.","Of them, Takeda Pharmaceutical is hiring the most, with 1,168 open roles.","Open roles at BridgeBio Pharma rose the most: from 56 on Oct 12, 2026 to 72 now."],"as_of":"2026-11-14","cite":"Alion, \"Neurocrine Biosciences competitors and alternatives: 10 similar companies compared on hiring and funding\", as of Nov 14, 2026. https://alion.io/company/neurocrine/competitors","indexable":true,"target":{"name":"Neurocrine Biosciences","url":"https://alion.io/company/neurocrine","domain":"neurocrine.com","open_roles":77,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"1001-5000","headquarters":{"city":"San Diego","country":"US"},"technologies":["Veeva","SAP BusinessObjects","Oracle"],"hiring_countries":["US","CH","GB"],"similarity":null},"competitors":[{"name":"Takeda Pharmaceutical","url":"https://alion.io/company/takeda","domain":"takeda.com","open_roles":1168,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"5000+","headquarters":{"city":"Tokyo","country":"JP"},"technologies":["GMP","SQL","Power BI"],"hiring_countries":["US","IN","PL"],"similarity":{"score":17.1,"shared_segments":["Rare Disease Therapeutics","Neurology & CNS Therapeutics"],"shared_technologies":["Python","SQL","Tableau","GCP","Databricks"],"same_hq_country":false}},{"name":"Acadia Pharmaceuticals","url":"https://alion.io/company/acadia-pharmaceuticals-inc","domain":"acadia.com","open_roles":34,"open_roles_change":{"since":"2026-10-12","from":37,"to":34,"pct":-8},"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"201-500","headquarters":{"city":"San Diego","country":"US"},"technologies":["GCP","Python","Machine Learning"],"hiring_countries":["US","DE","IT"],"similarity":{"score":16.35,"shared_segments":["Neurology & CNS Therapeutics","Rare Disease Therapeutics"],"shared_technologies":["Python","SQL","Tableau","GCP","Databricks"],"same_hq_country":true}},{"name":"Biogen","url":"https://alion.io/company/biogen-2","domain":"biogen.com","open_roles":179,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"5000+","headquarters":{"city":"Cambridge","country":"US"},"technologies":["GMP","CAPA","Veeva"],"hiring_countries":["US","CH","IE"],"similarity":{"score":16.13,"shared_segments":["Neurology & CNS Therapeutics"],"shared_technologies":["Python","SQL","Tableau","GCP","Databricks"],"same_hq_country":true}},{"name":"Ipsen","url":"https://alion.io/company/ipsen","domain":"ipsen.com","open_roles":163,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"1001-5000","headquarters":{"city":"Paris","country":"FR"},"technologies":["SAS","GCP","Power BI"],"hiring_countries":["FR","US","GB"],"similarity":{"score":15.85,"shared_segments":["Rare Disease Therapeutics","Neurology & CNS Therapeutics"],"shared_technologies":["Python","SQL","Tableau","GCP","Databricks"],"same_hq_country":false}},{"name":"Ovid Therapeutics","url":"https://alion.io/company/ovidrx","domain":"ovidrx.com","open_roles":2,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"201-500","headquarters":{"city":"New York","country":"US"},"technologies":["Good Clinical Practice","GCP","CAPA"],"hiring_countries":["US"],"similarity":{"score":15.45,"shared_segments":["Neurology & CNS Therapeutics","Rare Disease Therapeutics"],"shared_technologies":["GCP","Good Clinical Practice","CAPA"],"same_hq_country":true}},{"name":"AbbVie","url":"https://alion.io/company/abbvie","domain":"abbvie.com","open_roles":1154,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"5000+","headquarters":{"city":"North Chicago","country":"US"},"technologies":["Python","GCP","AWS"],"hiring_countries":["US","DE","IE"],"similarity":{"score":14.9,"shared_segments":["Neurology & CNS Therapeutics"],"shared_technologies":["Python","SQL","Tableau","GCP","Databricks"],"same_hq_country":true}},{"name":"Alnylam","url":"https://alion.io/company/alnylam","domain":"alnylam.com","open_roles":93,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"1001-5000","headquarters":{"city":"Cambridge","country":"US"},"technologies":["Python","GCP","CAPA"],"hiring_countries":["US","GB","DE"],"similarity":{"score":14.65,"shared_segments":["Rare Disease Therapeutics"],"shared_technologies":["Python","SQL","Tableau","GCP","Power BI"],"same_hq_country":true}},{"name":"Alkermes","url":"https://alion.io/company/alkermes","domain":"alkermes.com","open_roles":27,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"5000+","headquarters":{"city":"Dublin","country":"IE"},"technologies":["GMP","AWS","Veeva"],"hiring_countries":["US","IE"],"similarity":{"score":14.4,"shared_segments":["Neurology & CNS Therapeutics"],"shared_technologies":["Python","SQL","Tableau","GCP","Oracle"],"same_hq_country":false}},{"name":"Vertex Pharmaceuticals","url":"https://alion.io/company/vrtx","domain":"vrtx.com","open_roles":233,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"5000+","headquarters":{"city":"Boston","country":"US"},"technologies":["GCP","AI Agents","Python"],"hiring_countries":["US","GB","NL"],"similarity":{"score":14.3,"shared_segments":["Rare Disease Therapeutics"],"shared_technologies":["Python","SQL","Tableau","GCP","Databricks"],"same_hq_country":true}},{"name":"BridgeBio Pharma","url":"https://alion.io/company/bridgebiopharma","domain":"bridgebiopharma.com","open_roles":72,"open_roles_change":{"since":"2026-10-12","from":56,"to":72,"pct":29},"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"1001-5000","headquarters":{"city":"Palo Alto","country":"US"},"technologies":["Python","GCP","Claude"],"hiring_countries":["US","DE","CH"],"similarity":{"score":14.25,"shared_segments":["Rare Disease Therapeutics"],"shared_technologies":["Python","SQL","Tableau","GCP","Databricks"],"same_hq_country":true}}],"method":"Ranked by Alion's similar-companies engine (the MCP tool similar_companies): shared industry segments and the overlap of the two segment sets, technologies named in both companies' job postings, the same headquarters country, a size band near it. Open roles are the visible postings on Alion today; their change is shown only for boards that state posting dates.","html_url":"https://alion.io/company/neurocrine/competitors","json_url":"https://alion.io/company/neurocrine/competitors.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","built_at":"2026-11-14T03:58:57Z","generated_at":"2026-11-14T22:28:07Z"}}